Nicolas Schmidlin

Nicolas Schmidlin is a co-founder and board member of the Cologne-based independent asset management firm ProfitlichSchmidlin, which manages nearly €0.5 billion. With a background in economics from Goethe University Frankfurt and a master's in Investment Management from Cass Business School in London, he specializes in identifying undervalued stocks and bonds. Schmidlin has a keen interest in the life sciences sector, particularly in innovative pharmaceutical companies like Roche, which he believes has significant growth potential due to its focus on Alzheimer's disease treatments and a robust pipeline of drug candidates.